WEBULL

Edenred (ENXTPA:EDEN) Lifted Guidance, Is The Upside Already Priced In?

Simply Wall St · 2d ago

Why Edenred’s updated guidance matters for shareholders

Edenred (ENXTPA:EDEN) lifted its 2026 EBITDA guidance and confirmed expectations for EBITDA growth in 2027 and 2028, putting its Amplify 25-28 tech-focused plan in the spotlight for investors.

This shift in guidance comes alongside half year results to June 30, 2026 that showed sales of €1,360 million and revenue of €1,473 million, with net income of €214 million and basic EPS from continuing operations of €0.92.

See our latest analysis for Edenred.

Edenred’s share price has gathered momentum recently, with a 30 day share price return of 17.38% and a year to date share price return of 40.59%, while the 5 year total shareholder return is still down 37.33%, showing that recent optimism has yet to fully reverse longer term losses.

If Edenred’s guidance change has you rethinking where growth and technology intersect, this could be a good moment to scan a fresh set of opportunities using the 55 AI infrastructure stocks

The recent jump in Edenred’s share price could be read as confidence in Amplify 25-28’s earnings power, or as sentiment snapping back after years of weaker returns, which makes the current valuation worth unpacking next.

Most Popular Narrative: 4.1% Undervalued

The most followed narrative currently sees Edenred’s fair value at €27.53 compared with a last close of €26.41, framing the recent guidance upgrade against a modest discount.

The analysts have a consensus price target of €27.53 for Edenred based on their expectations of its future earnings growth, profit margins and other risk factors.

However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €37.0, and the most bearish reporting a price target of just €19.0.

Read the complete narrative.

Analysts are incorporating expectations of steady revenue expansion, a shift in margins, and a higher future earnings multiple. The tension lies in how those pieces interact. Curious which assumptions really carry this fair value calculation.

Result: Fair Value of €27.53 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, investors in Edenred still need to watch for regulatory shifts in key markets and rising competition from digital fintechs that could pressure fees, margins and client retention.

Find out about the key risks to this Edenred narrative.

Another view on Edenred’s valuation

The analyst narrative paints Edenred as modestly undervalued, yet the current P/E of 12.2x tells a more mixed story. It sits slightly above the European Diversified Financial industry at 11.8x, but below a fair ratio estimate of 17.7x, which points to both upside potential and re rating risk. Which signal do you put more weight on?

See what the numbers say about this price — find out in our valuation breakdown.

ENXTPA:EDEN P/E Ratio as at Jul 2026
ENXTPA:EDEN P/E Ratio as at Jul 2026

Next Steps

If the mix of optimism and caution around Edenred has you on the fence, take a closer look at the numbers, weigh both sides, and see the full picture with the 2 key rewards and 3 important warning signs.

Looking for more investment ideas beyond Edenred?

If Edenred’s story has sharpened your focus, do not stop here; new opportunities could be passing you by if you do not look wider.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.